ArticleACS omega2026
Core-Shell Biocompatible Piezoelectric Nanocomposite with Enhanced Cell Adhesion for Potential Biomedical Applications.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Flexible piezoelectric devices for biomedical applications often encounter a crucial balance between performance and biocompatibility. In this study, we introduce a core-shell approach to address this issue. A high-performance piezoelectric core, made of Rochelle salt embedded in a cytotoxic Ecoflex 00-30 matrix, was fully encapsulated by a multifunctional, biocompatible shell. This PDMS coating, reinforced with silanized cellulose nanofibers (Si-CNF), was surface-treated with cellulose nanofibers to actively support cell adhesion. The coating not only made the device nontoxic but also significantly improved its performance: the maximum output voltage increased by 163% (to 156.8 mV), and the elastic modulus nearly doubled (to 1.286 kPa). Additionally, the functionalized surface promoted HeLa cell adhesion comparable to standard culture substrates (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.